SCHEMBL1256184

SCHEMBL1256184

C1=CC2=COC=CC2C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9670232 0.98
SCHEMBL11214806 0.89
SCHEMBL4686582 0.79
SCHEMBL129419 0.68
SCHEMBL16684912 0.65
SCHEMBL216034 0.65
SCHEMBL3818681 0.65
SCHEMBL130666 0.65
SCHEMBL17749950 0.65
SCHEMBL130617 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113683590-B Coupling reagent with azafedone structure and application thereof in preparation of polypeptide and protein conjugate 南京大学 2023-05-09 CN claimed
CN-113683590-A Coupling reagent with azaphenanthrone structure and application thereof in preparation of polypeptide and protein conjugate 南京大学 2021-11-23 CN claimed
EP-0827501-A4 NON-NUCLEOSIDIC COUMARIN DERIVATIVES AS POLYNUCLEOTIDE-CROSS-LINKING AGENTS NAXCOR (US) 1998-06-10 EP claimed
EP-0827501-A1 NON-NUCLEOSIDIC COUMARIN DERIVATIVES AS POLYNUCLEOTIDE-CROSS-LINKING AGENTS NAXCOR (US) 1998-03-11 EP claimed
WO-1996028438-A1 NON-NUCLEOSIDIC COUMARIN DERIVATIVES AS POLYNUCLEOTIDE-CROSS-LINKING AGENTS NAXCOR (US) 1996-09-19 WO claimed
EP-0474767-A4 DOPAMINE AGONISTS 1992-07-08 EP claimed
EP-0474767-A1 DOPAMINE AGONISTS. ABBOTT LAB (US) 1992-03-18 EP claimed
WO-1990015056-A1 DOPAMINE AGONISTS ABBOTT LABORATORIES (US) 1990-12-13 WO claimed
US-12624309-B2 Enol ether properfume FIRMENICH SA (CH) 2026-05-12 US disclosed
US-12616948-B2 Polyamide microcapsules FIRMENICH SA (CH) 2026-05-05 US disclosed
EP-4090453-B1 MICROCAPSULES COATED WITH A POLYSUCCINIMIDE DERIVATIVE FIRMENICH & CIE (CH) 2026-04-29 EP disclosed
US-20260102324-A1 PERFUMING COMPOSITIONS COMPRISING A 2-(ALKYLSULFONYL)OCTAN-4-ONE FIRMENICH SA (CH) 2026-04-16 US disclosed
EP-4711037-A2 PERFUME FORMULATION FOR DELIVERY SYSTEM Firmenich SA (CH) 2026-03-18 EP disclosed
EP-4711438-A2 PERFUME DELIVERY SYSTEM Firmenich SA (CH) 2026-03-18 EP disclosed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO disclosed
EP-0474767-A4 DOPAMINE AGONISTS 1992-07-08 EP disclosed
EP-0474767-A1 DOPAMINE AGONISTS. ABBOTT LAB (US) 1992-03-18 EP disclosed
WO-1990015056-A1 DOPAMINE AGONISTS ABBOTT LABORATORIES (US) 1990-12-13 WO disclosed
EP-0138597-B1 DETERGENT BARS UNILEVER PLC (GB) 1989-08-23 EP disclosed
EP-0049953-B1 4-(SUBSTITUTED PHENYL)-NAPHTHALEN-2(1H)-ONES AND 2-OLS, PROCESSES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM PFIZER INC. (US) 1984-05-16 EP disclosed